{"product_id":"emerging-epidemics-9781118393239","title":"Emerging Epidemics","description":"\u003cb\u003eBook Synopsis\u003c\/b\u003e\u003cbr\u003e\u003cp\u003e\u003cb\u003eA global perspective on the management and prevention of emerging and re-emerging diseases\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEmerging infectious diseases are newly identified or otherwise previously unknown infections that cause public health challenges. Re-emerging infectious diseases are due to both the reappearance of and an increase in the number of infections from a disease that is known, but which had formerly caused so few infections that it was no longer considered a public health problem. The factors that cause the emergence or re-emergence of a disease are diverse.\u003c\/p\u003e \u003cp\u003eThis book takes a look at the world''s emerging and re-emerging diseases. It covers the diagnosis, therapy, prevention, and control of a variety of individual diseases, and examines the social and behavioral issues that could contribute to epidemics. Each chapter focuses on an individual disease and provides scientific background and social history as well as the current basics of infection, epidemiology, and control.\u003c\/p\u003e \u003cp\u003e\u003cbr\u003e\u003cb\u003eTable of Contents\u003c\/b\u003e\u003cbr\u003e\u003c\/p\u003e\u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003eAcknowledgments xvii\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 1 Prologue 3\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 3\u003c\/p\u003e \u003cp\u003eCausative Factors 7\u003c\/p\u003e \u003cp\u003eSalient Features 11\u003c\/p\u003e \u003cp\u003eEmerging Epidemics 11\u003c\/p\u003e \u003cp\u003eRe-Emerging Epidemics 17\u003c\/p\u003e \u003cp\u003eAntimicrobial Resistance 18\u003c\/p\u003e \u003cp\u003ePublic Health Implications 20\u003c\/p\u003e \u003cp\u003eReferences 22\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 2 Epidemics Fundamentals 24\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 24\u003c\/p\u003e \u003cp\u003eDefinitions 24\u003c\/p\u003e \u003cp\u003eTypes of Epidemics 26\u003c\/p\u003e \u003cp\u003eEpidemiological Triad 29\u003c\/p\u003e \u003cp\u003eForecasting an Epidemic 31\u003c\/p\u003e \u003cp\u003eContingency Plan 33\u003c\/p\u003e \u003cp\u003eInvestigation of Epidemics 35\u003c\/p\u003e \u003cp\u003eManagement of Epidemics 38\u003c\/p\u003e \u003cp\u003eControl of Epidemics 39\u003c\/p\u003e \u003cp\u003ePrinciples of Planning Emergency Services 41\u003c\/p\u003e \u003cp\u003eReferences 44\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 3 Disasters and Epidemics 46\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFundamentals 46\u003c\/p\u003e \u003cp\u003eContributory Factors 51\u003c\/p\u003e \u003cp\u003eInvestigation of Rumors 52\u003c\/p\u003e \u003cp\u003eReferences 54\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 4 Biosafety 56\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 56\u003c\/p\u003e \u003cp\u003eComponents 57\u003c\/p\u003e \u003cp\u003eHand Washing 61\u003c\/p\u003e \u003cp\u003ePreventing Needlestick Injuries 62\u003c\/p\u003e \u003cp\u003eSafe Transport of Biological Material 64\u003c\/p\u003e \u003cp\u003eSafe Decontamination of Spills 65\u003c\/p\u003e \u003cp\u003eSafe Handling of Dead Bodies 67\u003c\/p\u003e \u003cp\u003ePersonal Protective Equipment 69\u003c\/p\u003e \u003cp\u003eManagement of Biomedical Waste 69\u003c\/p\u003e \u003cp\u003eInfection Control Check List 71\u003c\/p\u003e \u003cp\u003eBiosafety Levels 71\u003c\/p\u003e \u003cp\u003eAccreditation of Hospitals and Laboratories 74\u003c\/p\u003e \u003cp\u003eReferences 75\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 5 Tuberculosis 76\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHistory 76\u003c\/p\u003e \u003cp\u003eMagnitude 78\u003c\/p\u003e \u003cp\u003eAgent Factors 81\u003c\/p\u003e \u003cp\u003eHost Factors and High-Risk Groups 88\u003c\/p\u003e \u003cp\u003eEnvironmental Factors 89\u003c\/p\u003e \u003cp\u003eModes of Transmission 90\u003c\/p\u003e \u003cp\u003ePathology and Immunology 91\u003c\/p\u003e \u003cp\u003eClinical Manifestations 96\u003c\/p\u003e \u003cp\u003eDiagnosis of Tuberculosis 101\u003c\/p\u003e \u003cp\u003eDirectly Observed Treatment, Short Course (DOTS) 119\u003c\/p\u003e \u003cp\u003eTuberculosis and HIV 135\u003c\/p\u003e \u003cp\u003eDrug-Resistant Tuberculosis 140\u003c\/p\u003e \u003cp\u003ePrevention and Control 142\u003c\/p\u003e \u003cp\u003eSocial and Cultural Factors 145\u003c\/p\u003e \u003cp\u003eReferences 148\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 6 Plague 154\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHistory of Plague 154\u003c\/p\u003e \u003cp\u003eMagnitude 155\u003c\/p\u003e \u003cp\u003eAgent Factors 157\u003c\/p\u003e \u003cp\u003eHost Factors 158\u003c\/p\u003e \u003cp\u003eEnvironmental Factors 159\u003c\/p\u003e \u003cp\u003eReservoir 159\u003c\/p\u003e \u003cp\u003eMode of Transmission 160\u003c\/p\u003e \u003cp\u003eClinical Manifestations 161\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 164\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 170\u003c\/p\u003e \u003cp\u003eClinical Management 170\u003c\/p\u003e \u003cp\u003ePrevention and Control 172\u003c\/p\u003e \u003cp\u003eReferences 174\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 7 Leptospirosis 176\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 176\u003c\/p\u003e \u003cp\u003eMagnitude 176\u003c\/p\u003e \u003cp\u003eAgent Factors 177\u003c\/p\u003e \u003cp\u003eHost Factors 179\u003c\/p\u003e \u003cp\u003eEnvironmental Factors 182\u003c\/p\u003e \u003cp\u003eMode of Transmission 183\u003c\/p\u003e \u003cp\u003ePathology and Immunology 183\u003c\/p\u003e \u003cp\u003eClinical Manifestations 185\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 189\u003c\/p\u003e \u003cp\u003eClinical Management 206\u003c\/p\u003e \u003cp\u003eSurveillance 210\u003c\/p\u003e \u003cp\u003eInvestigation of an Outbreak 211\u003c\/p\u003e \u003cp\u003ePrevention and Control 213\u003c\/p\u003e \u003cp\u003eReferences 217\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 8 Dengue 220\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 220\u003c\/p\u003e \u003cp\u003eMagnitude 221\u003c\/p\u003e \u003cp\u003eAgent Factors 222\u003c\/p\u003e \u003cp\u003eHost Factors 228\u003c\/p\u003e \u003cp\u003eEnvironmental Factors 230\u003c\/p\u003e \u003cp\u003eVector Biology 231\u003c\/p\u003e \u003cp\u003eClinical Features 235\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 244\u003c\/p\u003e \u003cp\u003eImmune Response to Dengue Virus 245\u003c\/p\u003e \u003cp\u003eClinical Management 248\u003c\/p\u003e \u003cp\u003eInvestigation of Outbreaks 253\u003c\/p\u003e \u003cp\u003ePrevention and Control 257\u003c\/p\u003e \u003cp\u003eReferences 259\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 9 Japanese Encephalitis 263\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHistory 263\u003c\/p\u003e \u003cp\u003eMagnitude of the Problem 264\u003c\/p\u003e \u003cp\u003eEpidemiology 266\u003c\/p\u003e \u003cp\u003eVector Biology 270\u003c\/p\u003e \u003cp\u003eClinical Features 270\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 271\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 272\u003c\/p\u003e \u003cp\u003eCase Management 275\u003c\/p\u003e \u003cp\u003ePrevention and Control 278\u003c\/p\u003e \u003cp\u003eReferences 280\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 10 Chikungunya Fever 283\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 283\u003c\/p\u003e \u003cp\u003eEpidemiology 284\u003c\/p\u003e \u003cp\u003eThe Chikungunya Virus 284\u003c\/p\u003e \u003cp\u003eClinical Features 291\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 298\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 300\u003c\/p\u003e \u003cp\u003eClinical Management 301\u003c\/p\u003e \u003cp\u003eInvestigation of Outbreaks 306\u003c\/p\u003e \u003cp\u003eTreatment 307\u003c\/p\u003e \u003cp\u003ePrevention and Control 308\u003c\/p\u003e \u003cp\u003eReferences 311\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 11 West Nile Fever 316\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEpidemiology 316\u003c\/p\u003e \u003cp\u003eGlobal Scenario 317\u003c\/p\u003e \u003cp\u003eThe Etiological Agent 318\u003c\/p\u003e \u003cp\u003eClinical Features 322\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 324\u003c\/p\u003e \u003cp\u003eClinical Management 326\u003c\/p\u003e \u003cp\u003eInvestigation of Outbreaks 327\u003c\/p\u003e \u003cp\u003ePrevention and Control 330\u003c\/p\u003e \u003cp\u003eReferences 336\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 12 Chandipura Virus Encephalitis 340\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eEpidemiology 340\u003c\/p\u003e \u003cp\u003eThe Chandipura Virus 341\u003c\/p\u003e \u003cp\u003eClinical Features 350\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 351\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 353\u003c\/p\u003e \u003cp\u003eClinical Management 354\u003c\/p\u003e \u003cp\u003eInvestigation of Outbreaks 356\u003c\/p\u003e \u003cp\u003ePrevention and Control 358\u003c\/p\u003e \u003cp\u003eReferences 359\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 13 Kyasanur Forest Disease 361\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 361\u003c\/p\u003e \u003cp\u003eEpidemiology 362\u003c\/p\u003e \u003cp\u003eVector Biology 363\u003c\/p\u003e \u003cp\u003eClinical Features 366\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 366\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 368\u003c\/p\u003e \u003cp\u003eCase Management 369\u003c\/p\u003e \u003cp\u003ePrevention and Control 371\u003c\/p\u003e \u003cp\u003eReferences 374\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 14 Hantavirus Disease 375\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 375\u003c\/p\u003e \u003cp\u003eEpidemiology and Global Scenario 376\u003c\/p\u003e \u003cp\u003eThe Etiological Agent 381\u003c\/p\u003e \u003cp\u003eClinical Features 387\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 390\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 390\u003c\/p\u003e \u003cp\u003eCase Management 393\u003c\/p\u003e \u003cp\u003ePrevention and Control 394\u003c\/p\u003e \u003cp\u003eReferences 396\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 15 Influenza 400\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHistorical Aspects 400\u003c\/p\u003e \u003cp\u003eGlobal Scenario 402\u003c\/p\u003e \u003cp\u003eAgent Factors 405\u003c\/p\u003e \u003cp\u003eHost Factors 418\u003c\/p\u003e \u003cp\u003eEnvironmental Factors 419\u003c\/p\u003e \u003cp\u003eMode of Transmission 421\u003c\/p\u003e \u003cp\u003eClinical Manifestations 422\u003c\/p\u003e \u003cp\u003eImmune Response to Influenza 424\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 427\u003c\/p\u003e \u003cp\u003eClinical Management 431\u003c\/p\u003e \u003cp\u003eSurveillance 434\u003c\/p\u003e \u003cp\u003eInvestigation of an Outbreak 437\u003c\/p\u003e \u003cp\u003ePrevention and Control 441\u003c\/p\u003e \u003cp\u003eAvian Influenza 445\u003c\/p\u003e \u003cp\u003eSwine Influenza 447\u003c\/p\u003e \u003cp\u003eReferences 450\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 16 Severe Acute Respiratory Syndrome 455\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 455\u003c\/p\u003e \u003cp\u003eEpidemiology 455\u003c\/p\u003e \u003cp\u003eCausative Agent 456\u003c\/p\u003e \u003cp\u003eTransmission of Severe Acute Respiratory Syndrome Virus 456\u003c\/p\u003e \u003cp\u003eClinical Features 457\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 457\u003c\/p\u003e \u003cp\u003eTreatment 458\u003c\/p\u003e \u003cp\u003ePrevention and Control 461\u003c\/p\u003e \u003cp\u003eReferences 461\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 17 Nipah Virus 462\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 462\u003c\/p\u003e \u003cp\u003eEpidemiology 463\u003c\/p\u003e \u003cp\u003eEtiological Agent 463\u003c\/p\u003e \u003cp\u003eTransmission 463\u003c\/p\u003e \u003cp\u003eClinical Features 466\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 467\u003c\/p\u003e \u003cp\u003ePrevention and Control 468\u003c\/p\u003e \u003cp\u003eReferences 469\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 18 Paragonimiasis 470\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMagnitude of the Problem 470\u003c\/p\u003e \u003cp\u003eThe Parasite: Paragonimus 471\u003c\/p\u003e \u003cp\u003eEpidemiology 475\u003c\/p\u003e \u003cp\u003eClinical Manifestations 478\u003c\/p\u003e \u003cp\u003eRadiological Features of Paragonimiasis 481\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 484\u003c\/p\u003e \u003cp\u003eDifferential Diagnosis 487\u003c\/p\u003e \u003cp\u003eClinical Management 487\u003c\/p\u003e \u003cp\u003ePublic Health Importance 488\u003c\/p\u003e \u003cp\u003eReferences 489\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 19 Melioidosis 492\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 492\u003c\/p\u003e \u003cp\u003eEpidemiology 493\u003c\/p\u003e \u003cp\u003eThe Etiological Agent: Burkholderia pseudomallei 495\u003c\/p\u003e \u003cp\u003eClinical Manifestations 498\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 501\u003c\/p\u003e \u003cp\u003eClinical Management 503\u003c\/p\u003e \u003cp\u003eInvestigation of an Outbreak 504\u003c\/p\u003e \u003cp\u003ePrevention and Control of Melioidosis 506\u003c\/p\u003e \u003cp\u003ePublic Health Importance 508\u003c\/p\u003e \u003cp\u003eReferences 508\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 20 Biowarfare and Bioterrorism 513\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 513\u003c\/p\u003e \u003cp\u003eHistorical Aspects 514\u003c\/p\u003e \u003cp\u003ePotential Agents 519\u003c\/p\u003e \u003cp\u003eEpidemiological Clues 545\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 548\u003c\/p\u003e \u003cp\u003eClinical Management 566\u003c\/p\u003e \u003cp\u003eBiosurveillance 568\u003c\/p\u003e \u003cp\u003eInvestigation of an Outbreak 573\u003c\/p\u003e \u003cp\u003ePreparedness and Containment 576\u003c\/p\u003e \u003cp\u003eReferences 578\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 21 Antimicrobial Resistance 585\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eIntroduction 585\u003c\/p\u003e \u003cp\u003eGlobal Scenario 586\u003c\/p\u003e \u003cp\u003eDrug-Resistant Organisms 588\u003c\/p\u003e \u003cp\u003eCauses of Drug Resistance 593\u003c\/p\u003e \u003cp\u003eMechanisms of Drug Resistance 595\u003c\/p\u003e \u003cp\u003eHost Factors 598\u003c\/p\u003e \u003cp\u003eHealth-Related and Economic Hazards 599\u003c\/p\u003e \u003cp\u003eLaboratory Diagnosis 601\u003c\/p\u003e \u003cp\u003eManaging Antimicrobial Resistance 607\u003c\/p\u003e \u003cp\u003ePrevention and Control 610\u003c\/p\u003e \u003cp\u003eReferences 612\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 22 Conventional Methods for Mosquito Control 615\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMosquito: Habits and Attractants 615\u003c\/p\u003e \u003cp\u003eEnvironmental Management 618\u003c\/p\u003e \u003cp\u003eAntilarval Measures 623\u003c\/p\u003e \u003cp\u003eChemical Adulticides 627\u003c\/p\u003e \u003cp\u003eRepellents 630\u003c\/p\u003e \u003cp\u003eInsecticide-Impregnated Bed Nets and Screens 632\u003c\/p\u003e \u003cp\u003eReferences 633\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 23 New and Potential Techniques: Mosquito Control 635\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eMyco-Insecticides 635\u003c\/p\u003e \u003cp\u003eEntomopathogenic Bacteria and Viruses 637\u003c\/p\u003e \u003cp\u003eHormonomimetic and Plant-Derived Substances 639\u003c\/p\u003e \u003cp\u003eLarvivorous Fish and Crustaceans 640\u003c\/p\u003e \u003cp\u003eDragonfly Nymphs 643\u003c\/p\u003e \u003cp\u003eProtozoa 643\u003c\/p\u003e \u003cp\u003eMermithid Nematodes 644\u003c\/p\u003e \u003cp\u003ePredator Larvae 645\u003c\/p\u003e \u003cp\u003eGenetic Engineering 646\u003c\/p\u003e \u003cp\u003eReferences 648\u003c\/p\u003e \u003cp\u003e\u003cb\u003eChapter 24 Other Disease Vectors and Their Control 651\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eHousefly 651\u003c\/p\u003e \u003cp\u003eSand Fly 653\u003c\/p\u003e \u003cp\u003eDeer Fly 653\u003c\/p\u003e \u003cp\u003eBlack Fly 655\u003c\/p\u003e \u003cp\u003eTsetse Fly 655\u003c\/p\u003e \u003cp\u003eWater Flea (Cyclops) 656\u003c\/p\u003e \u003cp\u003eSand Flea (Jigger or Chigoe Flea) 657\u003c\/p\u003e \u003cp\u003eRat Flea 658\u003c\/p\u003e \u003cp\u003eReduviid Bug 658\u003c\/p\u003e \u003cp\u003eTicks (Hard and Soft) 659\u003c\/p\u003e \u003cp\u003eLice 662\u003c\/p\u003e \u003cp\u003eCockroach 663\u003c\/p\u003e \u003cp\u003eMites (Chiggers) 664\u003c\/p\u003e \u003cp\u003eGeneral Principles of Vector Control 666\u003c\/p\u003e \u003cp\u003eIntegrated Vector Management 667\u003c\/p\u003e \u003cp\u003eRodents 670\u003c\/p\u003e \u003cp\u003eMethods for Rodent Control 671\u003c\/p\u003e \u003cp\u003eReferences 672\u003c\/p\u003e \u003cp\u003eGlossary 674\u003c\/p\u003e \u003cp\u003eIndex 683\u003c\/p\u003e","brand":"John Wiley and Sons Ltd","offers":[{"title":"Default Title","offer_id":49406863638871,"sku":"9781118393239","price":142.16,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0817\/1739\/5799\/files\/9781118393239.jpg?v=1730497374","url":"https:\/\/bookcurl.com\/products\/emerging-epidemics-9781118393239","provider":"Book Curl","version":"1.0","type":"link"}